Top 10 Reasons to Use EndoTool
Here are the top 10 reasons to use EndoTool:
10 – Confidence in Outcomes
EndoTool is the market leader for safe glucose management for hospitalized patients and is trusted by more than 180 hospitals in the United States.
9 – Simple Process
Once a facility begins using EndoTool, nurses follow a simple three-step process for safe dose recommendations. The process is easily completed through a bedside computer.
8 – EMR Integration
EndoTool has seamless integration with most major electronic medical records, including Epic, Allscripts, Cerner and Meditech.
7 – Customized System Parameters
Parameters may be customized for each facility and/or unit, eliminating the need for repetitive approval of the medical director, and providing caregivers more time to focus on direct patient care.
6 – Transition IV to SubQ
Using clinically driven protocols, EndoTool notifies the clinician when a patient has reached an optimal time for safe transition from intravenous to subcutaneous insulin therapy.
5 – Personalized Treatment
Insulin dose recommendations are based on unique patient parameters: blood glucose level, diabetes mellitus type, age, sex, weight, sCr, eGFR, steroids and any estimated residual extracellular insulin (EREI).
4 – EREI Calculation
Estimated residual extracellular insulin (EREI) accounts for previously administered insulin and is factored into next insulin dose recommendations. Similar to the concept of “insulin on board” for subcutaneous insulin therapy, but instead, EREI is used during intravenous insulin therapy.
3 – Specialize in the “Difficult”
Even in the most difficult patient scenarios (DKA, HNS, etc.), EndoTool provides a safe and efficient solution for glucose management with 99.4% of all patients achieving control.
2 – Eliminate Hypoglycemia
EndoTool achieves a 0.009% rate of hypoglycemia with blood glucose readings less than 40 mg/dL and a 0.290% rate of hypoglycemia with blood glucose readings less than 70 mg/dL.
1 – Safest Solution
More than 60 combined algorithms ensure that dosing is individualized and responsive to ongoing changes in each patient’s unique physiological response.